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ABSTRACT  1 
Background: Prolonged postprandial hypertriglyceridemia is a potential risk factor for 2 
cardiovascular diseases. In the context of obesity, this is associated with a chronic imbalance 3 
of lipid partitioning oriented towards storage and not towards -oxidation. 4 
Objectives: We tested the hypothesis that the physical structure of fat in a meal can modify 5 
absorption, chylomicron transport and further metabolic handling of dietary fatty acids. 6 
Design: 9 normal-weight and 9 obese subjects were fed 40g of milkfat (+
13
C-7 
triacylglycerols), either emulsified or not, in breakfasts of identical composition. We 8 
measured the postprandial triglyceride content and size of the chylomicron-rich fraction, 9 
plasma kinetics of 
13
C-fatty acids, exogenous lipid oxidation using breath-test/indirect 10 
calorimetry, and fecal excretion.  11 
Results: The emulsified fat resulted in earlier (>1h) and sharper chylomicron and 
13
C-fatty 12 
acids peaks in plasma compared to spread fat in both groups (P<0.0001). After 2h, the 13 
emulsified fat increased ApoB48 concentration (9.7 0.7 vs 7.1 0.9 mg/L; P<0.05) in the 14 
normal-weight subjects compared to the spread fat. For the obese subjects, emulsified fat 15 
resulted in 3-fold larger chylomicrons (218 24 nm) compared to the spread fat (P<0.05). The 16 
emulsified fat induced higher dietary fatty acid spillover in plasma and sharper 
13
CO2 17 
appearance, provoking increased exogenous lipid oxidation in each group: from 45% to 52% 18 
in normal-weight subjects (P<0.05), 40% to 57% in obese (P<0.01).   19 
Conclusions: This study supports a new concept of ―slow vs fast fat‖ whereby intestinal 20 
absorption can be modulated by structuring of dietary fat to modulate postprandial lipemia 21 
and lipid -oxidation in humans of different BMI. 22 
 23 
Key words: intestinal absorption; chylomicron; emulsion; stable isotopes; obesity. 24 
25 
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INTRODUCTION 26 
The metabolic importance of intestinal absorption and transport of nutrients in the 27 
postprandial period is recognized as important in the context of metabolic diseases such as 28 
obesity and type 2 diabetes (1). Regarding lipid metabolism, plasma kinetics, timing of peak 29 
of lipemia as well as chylomicron size are recognized as factors determining metabolic 30 
complications that are still an open field of research (2-4). For this reason, control of intestinal 31 
lipid absorption, the resulting chylomicron transport dynamics and ultimate dietary lipid fate 32 
may be an effective tool in the management of metabolic diseases. Recent studies have shown 33 
differential effects of oral sensory stimulation with high vs low amounts of dietary fat on 34 
intestinal lipid absorption (5). The possible effects of fatty acid (FA) profile of an oral fat load 35 
on chylomicron size have been suggested (6-10). While both fat load and composition can 36 
affect postprandial lipid absorption, few studies have investigated the effects of fat structure 37 
on the postprandial metabolism of an identical lipid load. In diabetes, the concept of 38 
―slow/low glycemic index carbohydrates and fast/high glycemic index carbohydrates‖ is well 39 
established and has facilitated the development of specific foods and/or cooking methods to 40 
control postprandial glycemia (11). We thus raised the question of whether a similar concept 41 
may be applicable to dietary fat according to the way it is structured in the meal. 42 
Dietary lipids are incorporated in food products with different physicochemical structures, 43 
e.g., in dispersed lipid droplets in oil-in-water emulsions like ice cream or in a continuous 44 
lipid phase in butter and margarine. Emulsions are the most widespread fat structures, in 45 
processed foods and enteral formulas, and are therefore of interest regarding their role in lipid 46 
digestion and absorption (12). Indeed, we have previously demonstrated in rodents the 47 
importance of lipid emulsified structure on FA absorption and -oxidation (13-15). However, 48 
the impact of fat structure on the kinetics of lipid absorption and dietary FA handling in 49 
humans remains to be elucidated. Such effects also deserve to be elucidated in obese subjects 50 
that present altered storage function of dietary FA in the postprandial state (16).  51 
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We therefore hypothesized that the physicochemical structure of the fat in a meal could 52 
modulate postprandial lipemia and fat partitioning: storage vs oxidation, and that the effect 53 
would be more pronounced in obese subjects. We investigated the metabolic response to fat-54 
containing meals (40 g) differing only in the structuring of fat, emulsified or not, in healthy 55 
young normal weight and obese men. Measurements included chylomicron number and size, 56 
FA β-oxidation and FA excretion in feces. The aim of this study was to define the 57 
contribution of fat structure and subject BMI on the postprandial lipemia and metabolism of 58 
dietary FA.  59 
 60 
SUBJECTS AND METHODS 61 
Study design 62 
The study was an open label trial with a cross-over randomized controlled design 63 
involving 2 days of metabolic testing separated by at least three weeks (Supplemental Figure 64 
1). It was conducted at the Human Nutrition Research Center Rhône-Alpes (CRNH-RA; 65 
Lyon, France) according to the Second Declaration of Helsinki and the French Huriet-66 
Serusclat law. The LIPINFLOX study was approved by the Scientific Ethics Committee of 67 
Lyon Sud-Est-II and AFSSAPS and registered at Clinical Trials (#NCT01249378). 68 
Volunteers received written and oral information and their medical history was reviewed. In 69 
addition they underwent a physical examination and fasting clinical analysis were assessed 70 
before enrolment. Informed written consent was obtained from all subjects. Volunteers 71 
performed trial in the period from April 2010 to July 2011. During the protocol, all subjects 72 
were asked to continue their regular diet and activity except for the week before and the 3-d 73 
period following each test day. Subjects were told to avoid foods naturally rich in 
13
C and 74 
were given a list. For 48 h prior to testing subjects were asked to refrain from consuming 75 
alcohol and to avoid exercise. In addition, subjects were provided with a standardized dinner 76 
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the evening prior to testing. Compliance was checked through diet records, 5 days before and 77 
3 days after each test day. 78 
After an overnight of fast, subjects ingested one of the two test breakfasts. The primary 79 
outcome measured was the effect of fat structure on postprandial lipemia. Secondary 80 
outcomes measured were the effect of fat structure and BMI on postprandial lipid metabolism. 81 
Previous studies on lipemia (17) and lipid oxidation (18) were used for the power analysis: a 82 
minimum sample size of 8 subjects per BMI group was calculated to be necessary to detect 83 
significant changes in these parameters. The treatments were randomized according to a 84 
random allocation sequence performed by a CRNH-RA biostatistician using Stat® v.11; two 85 
randomization lists were generated and stratified over BMI. Subjects were anonymized using 86 
a number corresponding to randomization sequence order. 87 
 88 
Subjects  89 
Twenty-two healthy men were recruited, 11 normal-weight (NW) and 11 obese, and 20 90 
completed the study (see Flow Diagram online). One subject in each group was not included 91 
in data analyses due to abnormal postprandial lipid metabolism; therefore 18 healthy subjects 92 
divided in two groups, 9 NW and 9 obese with comparable mean age were finally tested for 93 
the primary outcome, (Table 1). Volunteers were required to be non-smokers, sedentary or 94 
having <4h per week of physical activity and non-claustrophobic. We excluded persons under 95 
medication interfering with lipid metabolism, with psychological illness, or those with 96 
eating/metabolic disorders. In addition, subjects were required to have had stable weight, to 97 
be free of diabetes and to have not made blood donation for 3 months prior to the start of the 98 
study. Data were collected at CRNH-RA. 99 
 100 
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Test meals 101 
The test breakfasts were isoenergetic, equal in nutrient composition (Table 2) and both 102 
consisted of bread (50 g), skimmed milk (160 mL) and anhydrous milk fat (AMF; 40 g), 103 
containing 600 mg of tracers, either spread on bread or emulsified in skim milk. Both meals 104 
had the same composition as no additional emulsifier was added because milk proteins are 105 
sufficient to provide a submicronic milk fat emulsion. Prior to the test day, a mixture of 106 
labeled triacylglycerols (TAG) proportionally representing each FA type present in test fat 107 
was first incorporated into melted milk fat: 300 mg of [1,1,1-
13
C3] tripalmitin for long-chain 108 
saturated FA, 210 mg of [1,1,1-
13
C3] triolein for unsaturated FA and 90 mg of [1,1,1-
13
C3] 109 
trioctanoin for short- and medium-chain FA (99 atom% 
13
C, Eurisotop, Saint-Aubin, France). 110 
For the emulsion test, melted labeled milk fat was coarsly pre-mixed in skimmed milk 111 
(ProScientific Inc., Oxford, USA) and then further finely emulsified (4x 1 min, Vibra-cell
TM
 112 
Ultrasonic Processor, Sonics, Newtown, USA) (Supplemental Figure 2). Test products were 113 
then kept at 4°C overnight. 114 
 A second meal was served 5 hours after breakfast, containing pasta (200 g), turkey (100 115 
g), butter (10 g), olive oil (10 g), bread (50 g), stewed fruit (100 g)  which provided 713 kcal 116 
(2985 kJ) with 29%, 51% and 20% of energy as lipids (22.7 g), carbohydrates (91.5 g) and 117 
proteins (35.7 g) respectively. All subjects were given 10 minutes to eat breakfast and 30 118 
minutes for lunch. During the test, participants were allowed to drink 200 mL of water.  119 
 120 
Test fat characterization 121 
Emulsion droplet size was measured by Dynamic Light Scattering (Zetasizer Nano S, 122 
Malvern, France). Specific surface area of emulsion droplets was calculated using Laser Light 123 
Scattering (Mastersizer 2000, Malvern, France). The melting temperature and crystalline state 124 
of the fat was characterized by Differential Scanning Calorimetry (DSC) using a Q1000 DSC 125 
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(TA Instruments, New Castle, USA) and by powder X-ray Diffraction (XRD) using a D8 126 
Advance diffractometer (Bruker, Germany). 127 
 128 
Hunger assessment 129 
Subjective assessment of hunger was measured on a 10-cm visual analogue scale 2 min 130 
before breakfast and 2 min before lunch. Specific question to assess hunger was ―How hungry 131 
do you feel?‖. 132 
 133 
Metabolic explorations 134 
Blood samples were obtained at baseline and at regular intervals after the meal, from an 135 
antecubital arm vein through a catheter and collected in vacutainer sterile tubes (with EDTA 136 
when necessary). Plasma was separated by centrifugation (1500 g, 10 min, 4°C) and stored at  137 
-20°C until analysis or at 4°C for separation of the chylomicron-rich fraction (CMRF). 138 
Metabolic tests were divided into postprandial phases including a first period of 5 hours (0 139 
to 300 min) post-breakfast in the morning, a second period of 3 hours post-lunch (300 to 480 140 
min) and the entire exploration day (0 to 480 min). 141 
Indirect calorimetry was performed during metabolic testing using a Deltatrac II™ 142 
calorimeter (Sensormedics, Yorba Linda, CA, USA). Respiratory exchanges (VO2 and VCO2) 143 
were recorded for periods of 30 or 60 minutes during the 8-h test period. Substrate oxidations 144 
were calculated using Ferrannini’s equations (19). Urine was collected at 0, 300 and 480 min 145 
to determine nitrogen excretion for oxidation calculations. For breath test, expired gas 146 
samples were obtained at baseline, each 30 min for 8-h and then at 720 and 1440 min to check 147 
return to baseline. Subjects had to collect and freeze their stools individually over 72 h after 148 
the test day. 149 
 150 
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Plasma metabolite and hormone measurements 151 
Non esterified fatty acid (NEFA) concentrations were determined by an enzymatic 152 
method Wako® (Neuss, Deutschland). ApoB48 was measured by ELISA (Gentaur, France). 153 
Insulin concentration was determined by RIA (CISBIO Bi insuline IRMA, France). 154 
 155 
Isolation and analysis of chylomicron-rich fractions  156 
To collect the CMRF, containing chylomicrons and their large remnants, 250 µL of 157 
plasma was deposited below a layer of 850 µL of distilled/deionized water and centrifuged at 158 
80 000 rpm for 30 min using a Sorvall Kendro ultracentrifuge (Asheville, NC, USA). The 159 
floating layer was collected and stored at -80°C. TAG and cholesterol concentrations of 160 
CMRF were measured with a lipase glycerokinase and a cholesterol esterase/oxidase method, 161 
respectively, on a AU 2700 Beckman Coulter® (O’ Cllagan’s mils, Ireland) and expressed as 162 
differences in concentration over baseline. Hydrodynamic diameter of CMRF was measured 163 
by dynamic light scattering at 25°C using a ZetaSizer NanoS (Malvern, UK) using 1.0658 cP 164 
and 1.33 as viscosity and refractive index of the aqueous phase, respectively. Gravity-165 
separated fraction containing chylomicrons and their large remnants are reported to size in the 166 
range 70-450 nm (20-22), and postprandial increase in cholesterol content of such fraction is 167 
about <0.2 mM (23). Our fraction collected by ultracentrifugation contained particles of mean 168 
diameter up to 200-300 nm and with postprandial increase in cholesterol of <0.15 mM in NW 169 
and <0.25 mM in obese subjects. Our CMRF is thus typical of fractions that are rich in 170 
chylomicrons and that also contain large remnants. 171 
 172 
13
C-fatty acids in plasma lipids, NEFA, CMRF and stools 173 
Sample preparation. Internal standards were added according to the fraction analyzed 174 
(heptadecanoic acid or glycerol triheptadecanoate). 175 
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Plasma processing. Plasma samples were submitted to direct methylation as described 176 
previously (24).  177 
NEFA processing. Total lipids were extracted from plasma aliquots at 120 min after 178 
breakfast consumption (700µL) with 3 mL of a mixture of chloroform/methanol (2:1 v/v) 179 
according to Folch method (25). NEFA fractions were obtained therefrom by TLC on silica-180 
gel plates with a mobile phase of hexane/diethyl ether/acetic acid (80:20:1 v/v/v). NEFA were 181 
derivatized to Fatty Acid Methyl Esters (FAMEs) (24). 182 
CMRF processing. Lipids were extracted from CMRF at 120 min after breakfast 183 
according to Folch method (25). TAG fractions were then processed as the NEFA fractions 184 
above, to obtain the FAMEs from CMRF. 185 
Stool processing. Fecal collections were weighed, homogenized and a precisely weighed 186 
aliquot was collected. Total lipids were extracted according to a modification of the Folch 187 
method and derivatized to obtain FAMEs (24). 188 
Sample analysis. The amounts of FA in stools, plasma and NEFA were assessed by 189 
GC/MS using a quadrupole mass spectrometer connected to a gas chromatograph (MS 5975 190 
and GC6890, Agilent Technologies, Massy, France). The isotopic enrichment of palmitic and 191 
oleic acids was determined using GC/C/IRMS (Isoprime, GV Instruments, Manchester, 192 
UK)(24). The 
13
C enrichments were expressed as atom percent excess (APE). The plasma 193 
concentrations of non-esterified labelled palmitic and oleic acids (called [
13
C-NEFA]) and 194 
non-esterified unlabelled palmitic and oleic acids (called [
12
C-NEFA]) were also obtained 195 
from these analyses. 196 
 197 
Calculations associated with apparent dietary fatty acid “spillover”  198 
NEFA analysis at 120 min after breakfast was used to calculate 
13
C enrichment in plasma 199 
NEFA as: [
13
C-NEFA] / ( [
13
C-NEFA] + [
12
C-NEFA] ) (expressed in % enrichment). The 200 
proportion of exogenous NEFA in total plasma NEFA, expressed in %, was estimated by the 201 
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ratio of the 
13
C enrichment in plasma NEFA to the 
13
C enrichment of corresponding FA in the 202 
ingested milk fat. The proportion of exogenous
 
fatty acids in plasma that was present in non-203 
esterified form in the sum of pools NEFA+CMRF was calculated as: [
13
C-NEFA]plasma /  204 
([
13
C-NEFA]plasma + [
13
C-FACMRF]plasma ), where [
13
C-FACMRF]plasma is the plasma concentration 205 
of 
13
C-FA esterified in CMRF-TAG = [
13
C-FA]CMRF / ( [
13
C-FA]CMRF + [
12
C-FA]CMRF ) x 3 x 206 
[CMRF-TAG]plasma. 207 
 208 
Calculations of exogenous lipid oxidation from indirect calorimetry & breath tests  209 
Exogenous lipid oxidation was calculated according to Binnert et al. (18) from data of 210 
indirect calorimetry and breath tests. Here the formula was adapted to our use of 3 labeled 211 
triglycerides as follows:  212 
Exogenous lipid oxidation (% of ingested fat) = 213 
       
      
100
4.22
100/)(2/
2023022 




dARFCBA
COVtCOAPtCOAPtCOAP
 214 
 215 
With:  (A)=      2766.473/09.0100/0:813 CTGAP  216 
   (B)=      5130.810/30.0100/0:1613 CTGAP  217 
  (C)=      5740.888/21.0100/1:1813 CTGAP  218 
Where AP CO2 (t) is the AP value of the expired CO2 at time t, AP CO2 (t0) is the AP value of 219 
the expired CO2 at time t0, AP tracers is the calculated AP value of the labeled mixture of 220 
TAG (tracers) and 

V CO2 is the production rate of expired CO2 (indirect calorimetry). Mean 221 
molecular weights of trioctanoin, tripalmitin and triolein are 473.66 g/mol, 810.30 g/mol and 222 
888.40 g/mol, respectively. Mean number of carbons in trioctanoin, tripalmitin and triolein 223 
are 27, 51 and 57, respectively. dARF (Acetate Recovery Factor) is the correction factor for 224 
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incomplete recovery of 
13
C bicarbonate (0.505 for NW; 0.453 for obese (26)) and 22.4 is the 225 
molar volume (L) of CO2.  226 
 227 
Kinetic parameters 228 
We calculated the incremental area under curve (iAUC); maximum postprandial 229 
concentration, delta and diameter (Cmax, ∆max, dmax); time for appearance of these maximum 230 
parameters (tmax) and appearance/enlargement-rates between 0 and 60 min. 231 
 232 
Statistical analysis 233 
Each subject served as his own control. All data are presented as means ±SEM (n=9 per 234 
group) and were analyzed with Statview 5.0 software (Abacus Concept, Berkeley, CA). 235 
Postprandial data were compared by analysis of variance (ANOVA) for repeated measures 236 
followed by post-hoc test (Fisher PLSD) for statistical effects of (i) time alone (Ptime) over the 237 
first postprandial period (0-300min), (ii) meal alone (Pmeal) independently of the time in the 238 
postprandial period and (iii) interaction of both factors, time and meal (Ptimexmeal). Kinetic 239 
parameters were compared by two-way ANOVA followed by Fisher PLSD according to meal 240 
and BMI (Pmeal, PBMI, PmealxBMI) and time period before/after lunch (PmealxBMIxtime). Multiple 241 
comparisons regarding tracer excretion in feces were performed using ANOVA followed by 242 
Bonferroni post-hoc test. Comparisons between meals within subject groups were performed 243 
using a paired Student’s t-test and comparisons between subject groups within meals with an 244 
unpaired Student’s t-test. Differences were considered significant at the P< 0.05 level. 245 
 246 
RESULTS 247 
Properties of emulsion vs spread fat 248 
The emulsion droplet size (Table 3; Supplemental Figure 3) indicates the homogenization 249 
was effective in producing the emulsions. The emulsion had an approximately ~70000-fold 250 
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greater surface area than the spread fat. To control for the possibility that the different 251 
metabolic effects could be attributed to the fat melting properties, we measured melting 252 
profiles and crystalline structures in all conditions (with or without tracers, emulsified or not, 253 
Supplemental Figure 4). According to these analyses, the test fat differed only by their 254 
structure (Table 3). 255 
 256 
Hunger feeling 257 
At the end of the first postprandial period (0-300 min) just before lunch, normal-weight 258 
subjects felt similarly hungry regardless of breakfast type (Supplemental figure 5). In contrast, 259 
obese subjects felt hungrier after emulsion than spread fat (P< 0.05; Supplemental figure 5). 260 
Of note, before breakfasts, all subjects felt equally hungry (not shown). 261 
 262 
Postprandial concentration profile and size of chylomicron-rich fraction 263 
Figure 1A-B shows that in both groups, CMRF-TAG rapidly increased (60 min) after 264 
ingestion of emulsified fat and peaked at 3-4 h (tmax in Table 4). The emulsion induced a 265 
significantly earlier and sharper increase in CMRF-TAG than the spread fat (Table 4: tmax and 266 
appearance-rate0-60min; P< 0.001). These differences were dramatically marked in the obese 267 
subjects, with a significant delay in absorption of the spread fat from 0 to 300 min compared 268 
to NW subjects (P< 0.01, Table 4). At the end of the test, CMRF-TAG of NW subjects 269 
returned to lower values regardless of fat structure. The obese subjects showed different 270 
profiles, with CMRF-TAG remaining elevated at the end of the spread fat test: e.g. at 480 271 
min, 0.61 ± 0.15 mmol/L for spread vs 0.27 ± 0.06 mmol/L for emulsion above fasting 272 
baseline (P< 0.05). These differences in profile before and after lunch according to obese state 273 
and meal type are supported by different BMI x meal x time interactions for the Δmax and 274 
iAUC of CMRF-TAG (Table 4). 275 
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Mean CMRF size sharply increased in both groups from the first hour after emulsion 276 
(Figure 1 C-D; Pmeal< 0.05 for enlargment-rate0-60min, Table 4). For NW subjects, CMRF 277 
diameters were similar for spread fat and emulsion all along the test. In obese subjects, CMRF 278 
diameters became equal for both meals at 300 min. We can note that in the period from 0 to 279 
240 min, CMRF diameter in obese subjects was higher after emulsion vs spread fat from 0 to 280 
240 min (Pmeal< 0.05 and Ptime< 0.001). Altogether, obese subjects presented larger CMRF 281 
than NW subjects (P< 0.01 for dmax 0-480 min, Table 4) with persistence of large CMRF after 282 
the second meal for spread fat. 283 
 284 
Plasma concentration profile of ApoB48 285 
Figure 1E-F shows that plasma ApoB48 changed over time in both groups after both 286 
breakfasts (Ptime< 0.0001) and differently according to the type of breakfast for NW subjects 287 
(Ptimexmeal=0.001). At 120 min, NW subjects accumulated more ApoB48 after consumption of 288 
emulsion than spread fat (7.08 ±0.86 mg/L for spread fat vs 9.73 ±0.69 mg/L for emulsion, P< 289 
0.05) and compared with obese subjects for emulsion (7.47 ±0.78 mg/L, P< 0.05). 290 
 291 
Plasma concentration profile of 
13
C-fatty acid tracers and fecal loss 292 
Figure 2A-B-C-D shows a change in plasma 
13
C-palmitic and 
13
C-oleic acids over time in 293 
both groups after both breakfasts (Ptime< 0.0001). 
13
C-palmitic acid appeared earlier and 294 
sharper in plasma when it was in emulsion, differences between breakfasts being greater for 295 
obese (Pmeal= 0.007). Plasma concentrations of 
13
C-oleic acid were higher during 5h of 296 
emulsion digestion, especially for obese subjects (Pmeal= 0.018 and Ptimexmeal= 0.0002). For 297 
both tracers, a second peak was observed at 360 min, after ingestion of the second meal. 298 
During the first 300 min for obese subjects, the iAUC for plasma 
13
C-FA were 299 
significantly higher after consumption of emulsion vs spread fat (P< 0.05, Figure 2B-D). 300 
iAUC after spread fat were lower for obese vs NW subjects (P< 0.05, Figure 2B-D).  301 
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Fecal excretion of 
13
C-palmitic acid was higher than that of 
13
C-oleic acid (Figure 2E). 302 
There was no effect of breakfast type on fecal excretion of 
13
C-palmitic acid or  
13
C-oleic acid 303 
in the two groups. 304 
 305 
Plasma concentration profile of insulin and NEFA and apparent dietary FA spillover 306 
Figure 3A-B-C-D shows a significant change in plasma insulin and NEFA over time after 307 
the two breakfasts in both groups (Ptime< 0.0001). Over the first 300 min, the NEFA profile 308 
indicated a meal type x time interaction in both groups, with the decrease in plasma NEFA at 309 
120 min being lower for emulsion than spread (Figure 3C-D). Therefore, we measured 
13
C 310 
enrichment in plasma NEFA at 120 minutes (Figure 3E) to estimate whether this would result 311 
from the contribution of exogenous FA, so-called apparent fatty acid ―spillover‖. We 312 
observed higher apparent ―spillover‖ during the postprandial phase of emulsion vs spread fat, 313 
in both groups (P< 0.05 for NW and P< 0.01 for obese subjects, Figure 3E). The contribution 314 
of exogenous FA to total NEFA in NW subjects was 42% for spread vs 79% for emulsion, 315 
and was lower in obese, 4% for spread vs 50% for emulsion (meal effect, P< 0.01; BMI 316 
effect, P< 0.01; no meal x BMI interaction). Moreover, in NW subjects, the proportion of 317 
exogenous FA being in non-esterified form in plasma at 120 min was 10.6 % for spread vs 318 
18.7 % for emulsion, i.e. 1.8-fold increase, and in obese 10.1 % for spread vs 15.0% for 319 
emulsion, i.e. 1.5-fold increase (P<0.05 for spread vs emulsion; no significant effect of BMI 320 
nor meal x BMI interaction). In the same time emulsification increased total plasma NEFA by 321 
2.2-fold in NW and by 1.6-fold in obese subjects (Figure 3C-D). Altogether, this means that 322 
more than 80 % of the increase of plasma NEFA due to emulsification may be explained by 323 
an increased amount of exogenous fatty acids being released non-esterified in plasma 324 
(spillover). 325 
 326 
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Postprandial appearance of label in expired CO2 327 
The 
13
C appearance in expired CO2 represents the final product of FA -oxidation. A 328 
significant change in APE occurred over time in both groups (Ptime< 0.0001; Figure 4A-B). In 329 
both groups, APE was higher after consumption of emulsion vs spread fat over the first 300 330 
min, indicating improvement of dietary fat -oxidation using emulsified form. APE returned 331 
to baseline after 720 min. An effect of BMI was also observed with  higher appearance- 332 
rate0-60min in NW than obese subjects (P< 0.01; Table 4). 333 
Inserts in Figure 4A-B show that AUC of expired 
13
CO2 after 300 min for the emulsion 334 
was significantly higher than for spread fat in both groups (P< 0.01 for NW subjects and P< 335 
0.001 for obese subjects). Besides, over 0 to 720 min, obese subjects presented higher AUC 336 
of expired 
13
CO2 after consuming emulsion vs spread fat (P< 0.05, Figure 4B insert). 337 
Altogether, the structuring of fat in the meal significantly affected the kinetic parameters of 338 
13
CO2 air enrichment regardless of BMI while BMI affected AUC and appearance-rate 0-60min 339 
(Table 4). 340 
 341 
Exogenous lipid fate 342 
We studied the metabolic handling of exogenous lipids by evaluating the fractions of 343 
ingested lipids that have been either oxidized or lost in feces, and so estimated the remaining 344 
fraction stored in body pools. For the same quantity and composition of ingested fat, all 345 
subjects -oxidized FA better when fat was emulsified (Figure 4C). In turn, the calculated 346 
fraction of ingested lipids oriented towards storage in body pools was lower after emulsion vs 347 
spread consumption. After accounting for the part of exogenous lipids lost in feces (Figure 348 
4C), the percentage of exogenous lipid oxidation according to the fraction that has been 349 
intestinally absorbed was higher for NW and obese subjects after emulsion vs spread fat (P< 350 
0.05 and P< 0.01, respectively, Figure 4D). Total lipid oxidation was unchanged with the two 351 
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test meals in both groups but with a greater relative contribution of exogenous lipids ingested 352 
at breakfast as emulsion vs spread fat (Figure 4E). 353 
 354 
DISCUSSION 355 
Postprandial triglyceridemia is the first step in the metabolization of dietary lipids. 356 
Ingested FA are firstly present in plasma TAG in the form of intestinally secreted 357 
chylomicrons, which further lead to large remnants after hydrolysis by lipoprotein lipase (10, 358 
22). The next step concerns trafficking of FA towards β-oxidation or storage that is of utmost 359 
importance regarding the metabolic impact of these dietary FA. We therefore investigated 360 
whether structuring fat in the meal could modify postprandial lipid metabolism, from the 361 
amount and size of chylomicrons to -oxidation, including fecal loss. To this aim, labeled 362 
breakfasts containing either spread or emulsified fat were fed to NW and obese subjects. Test 363 
meals were designed to be of equal composition. Thus, factors like FA composition or protein 364 
content cannot be involved in the presently observed differences in lipid metabolism, which 365 
can be uniquely attributed to the fat physico-chemical structure in the meal. The postprandial 366 
chylomicron TAG profile after emulsion consumption differed from that of the spread fat, 367 
with the peak being more rapidly achieved, more pronounced and more quickly cleared, 368 
especially in obese subjects. This is consistent with reports of enhanced FA absorption when a 369 
simple bolus of vegetable oil was emulsified in humans (27) and rodents(14, 15, 28). One 370 
explanation is that our emulsion had ~70000-times greater surface area available for lipases 371 
than spread fat, which is reported to enhance lipolysis and absorption (29). Enteral emulsions 372 
of different droplet sizes, ~1 vs ~10 µm (14.5-fold difference in fat surface area), were shown 373 
to result in small differences only in postprandial lipemia in humans (17). The dramatic 374 
differences observed in the present work are due to the greatest differences in fat structure. Of 375 
note, postprandial lipid metabolization was previously found faster using unemulsified than 376 
emulsified milk fat in rats (14). Differences with the present results can be explained by (i) 377 
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rodent physiology of bile flow that is different from humans (30), and (ii) unemulsified 378 
melted milk fat being force-fed intragastrically, prior to the proteinaceous phase. This could 379 
have favored lipid emptying in the upper intestine and a rapid rise of plasma TAG in rats.  380 
Our study also provides a proof of concept that effects of fat structure in the meal can occur in 381 
a real mixed meal, while previous studies used oil or emulsion bolus fed orally or 382 
intragastrically (17, 29). Regarding emulsifier type, our fat was emulsified by the proteins 383 
naturally present in skim milk. Emulsions stabilized with caseins and monoacylglycerols were 384 
recently reported to result in lower postprandial plasma TAG than those formulated with 385 
lecithin in non-obese humans (31), which can be explained by lower in vitro digestive 386 
lipolysis (32). Because obese men were the most affected by emulsification, further work 387 
should test the effect of emulsifiers on postprandial lipid metabolism. The importance of 388 
sensory exposure to lipids on postprandial metabolism in humans was also recently revealed 389 
(5). Therefore, we cannot exclude a contribution of oral fat perception in our results.  390 
TAG-rich lipoproteins remaining elevated all along the postprandial phase are an 391 
independent CVD risk factor (3, 4), which can be mechanistically related to the atherogenic 392 
potential of small chylomicron remnants (21, 22). In this study, we collected CMRF fractions 393 
containing chylomicrons and their large remnants. The latter do not contribute significantly to 394 
the formation of small atherogenic remnants because of direct hepatic clearance (33). 395 
However, the role of TAG-rich particles is still debated, underlining that this is still an open 396 
field needing further studies (1, 2). In this context, our study shows for the first time in NW 397 
and obese men that postprandial lipemia profile can be modulated by structuring the fat in a 398 
mixed meal. Therefore, the study of atherogenic small particles in the postprandial phase after 399 
consumption of differently structured lipids in the meal should now be performed. 400 
Obese men presented a delayed increase of CMRF-TAG after spread fat. Overweight men 401 
were also reported to present delayed TAG-rich lipoprotein metabolism after a high-fat load 402 
(34). Our observed differences between the two breakfasts in obese men could be explained 403 
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by their lower pancreatic secretion and lower levels of gallbladder emptying compared with 404 
lean men (35). Therefore, obese subjects can better hydrolyze fat when it is pre-emulsified. 405 
Moreover, fine stable emulsions were reported to be emptied faster and to cause greater 406 
release of cholecystokinin than those that broke and layer in the stomach (36, 37). We can 407 
thus suggest that the fat absorption delay observed with spread fat can be due to layering in 408 
the stomach and thus delayed emptying. Of note, immediately after lunch, a peak of 
13
C-FA 409 
appeared in plasma. This so-called ―second-meal effect‖ is known as the contribution of lipids 410 
from a meal to lipemia after the next meal (38). For obese men, the marked delay in lipemia 411 
appearance after spread fat cumulated with the second meal effect, causing high lipemia until 412 
the test ended. In contrast, obese subjects (without fasting hyperlipidemia herein) did not have 413 
difficulties in absorbing the emulsion, with a final return of lipemia to baseline.  414 
In NW subjects, higher CMRF-TAG after the emulsion corresponded transiently to an 415 
increased number of particles, as shown by the similar CMRF-size with an increased ApoB48 416 
level at 120 min. In obese subjects however, ApoB48 levels remained similar, i.e., the 417 
increase in lipemia after emulsion was due to an increased CMRF size. High particle numbers 418 
estimated by ApoB48 level are reported to lead to increased chylomicron remnant numbers, 419 
hence potentially increased atherosclerotic risk (10, 21). It would now be useful to explore the 420 
chronic metabolic impact of fat structure, especially regarding ApoB48-containting particles. 421 
The few reports about metabolic effects of emulsions have solely studied lipemia or 422 
plasma FA concentrations as endpoints. For the first time to our knowledge, our study shows 423 
that fat emulsification further affects the metabolic handling of exogenous FA, including -424 
oxidation. Early appearance of 
13
CO2 was due to the rapid -oxidation of short-chain FA that 425 
are directly absorbed in the portal vein and oxidized by the liver (39). Obesity is associated 426 
with a defect in the -oxidation of dietary FA (18, 40-42). Hodson et al. recently challenged 427 
this idea by showing greater FA -oxidation in obese men and attributed this to specific FA 428 
acid partitioning (43). We highlight that exogenous FA oxidation can be enhanced in obese 429 
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men by emulsifying fat. Discrepancies between reports can thus be explained by the present 430 
―fast vs slow lipid‖ notion. Indeed, lower -oxidation in obese vs lean subjects was observed 431 
using a single oil bolus (18) whereas higher -oxidation in obese was observed when the 432 
tracer was dispersed into an emulsion (43). This aspect had not been taken into account by 433 
previous authors. Moreover, emulsification is now advised to enhance the intestinal 434 
absorption of essential fatty acids (27). However, our results highlight the risk that such 435 
essential FA quickly absorbed can be lost in the -oxidation process rather than being 436 
bioavailable for cell membrane turnover. Therefore, further studies on the structuring of oils 437 
rich in essential PUFA should now investigate their final postprandial metabolic fate. 438 
The effect of emulsification on exogenous lipid oxidation cannot be due to differences in 439 
intestinal absorption because of similar fecal excretion. Total lipid oxidation during the test 440 
day was unchanged by fat structuring, as well as total energy expenditure and diet-induced 441 
thermogenesis. However, the source of -oxidized FA was different: using emulsion, 442 
exogenous FA ingested at breakfast were shunted towards -oxidation pathways. Using 443 
spread fat, more endogenous FA and/or exogenous FA ingested at lunch were oxidized so that 444 
exogenous FA ingested at breakfast were more oriented towards storage. Therefore, 445 
regardless of energy balance, FA metabolism is changed by lipid structure. This is consistent 446 
with the greater FA spillover after emulsion. It can be explained by the faster intestinal 447 
absorption, resulting in enhanced lipolysis of chylomicrons that generates exogenous NEFA 448 
(44). Their early influx can serve as fuel for tissues and explain their higher contribution to 449 
total FA oxidation with emulsion. However, high NEFA can also constitute a risk for ectopic 450 
fat accumulation (44). Another aspect in obesity research concerns energy balance and satiety 451 
regulation (45, 46). Just before lunch, our obese subjects felt hungrier after emulsion than 452 
spread fat (visual analog scales, Supplemental figure 5). Further trials could test the impact of 453 
fat structuring at breakfast on satiety regulation at lunch and energy balance. 454 
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In summary, we demonstrate that the postprandial metabolic handling of dietary FA can be 455 
significantly modified by emulsifying the fat in the meal, especially in obese subjects. The 456 
clinical perspectives of this first study should thus not be underrated. This study supports the 457 
further exploration of a possible dietary concept of ―fast vs slow lipid‖ for the nutritional 458 
management of metabolic diseases through food formulation. Our results in the postprandial 459 
phase raise the questions of whether (i) daily ingestion of ―fast vs slow fat‖ would result in 460 
different lipid metabolisms, adiposity and/or cardiovascular risk markers in the long term and 461 
(ii) the composition and structuring of dietary lipids could be optimized to this aim. 462 
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Table 1. Anthropometric and fasting metabolic subject parameters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Data are means ± SEM. Groups are compared using unpaired Student’s t-test. 
 Normal weight 
(n=9) 
Obese 
(n=9) 
P value 
Anthropometric parameters    
Age (years) 28.3 ± 1.4 30.2 ± 2.2 ns 
Body weight (kg) 72.0 ± 2.1  101.2 ± 1.9 < 0.0001 
BMI (kg.m
-
²) 22.3 ± 0.5 31.7 ± 0.3 < 0.0001 
Waist circumference (cm) 83.3 ± 1.6 105.9 ± 0.8 < 0.0001 
    
Fasting metabolic parameters    
Glucose (mM) 4.94 ± 0.16 5.19 ± 0.15 ns 
Insulin (mIU/L) 3.75 ± 0.59 7.14 ± 0.95 0.008 
HOMA 0.85 ± 0.14 1.69 ± 0.25 0.009 
Total cholesterol (mM) 4.85 ± 0.22 4.89 ± 0.24 ns 
HDL cholesterol (mM) 1.51 ± 0.10 1.09 ± 0.06 0.004 
LDL cholesterol (mM) 3.03 ± 0.27 3.11 ± 0.21 ns 
Triacylglycerols (mM) 0.85 ± 0.06 1.39 ± 0.18 0.017 
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Table 2. Nutritional composition of the test breakfasts containing either spread or emulsified 
fat enriched with 
13
C-labelled triglycerides. 
1
 Identical nutrient composition for both spread and emulsion breakfasts. 
2
 Fatty acid profile of TAG includes 68.6% SFA, 28.1% MUFA and 3.3% PUFA. 
3
 Natural vanillia-flavoured. 
Breakfast composition
1
 
 Quantity      
(g or mL) 
Carbohydrates 
(g) 
Proteins      
(g) 
Lipids        
(g) 
Anhydrous Milk Fat
2
 40 - - 40 
Skimmed milk
3
 160 7.5 5.3 0.3 
Bread 50 28 4 0.5 
[1,1,1-
13
C3] trioctanoin 0.09 - - 0.09 
[1,1,1-
13
C3] tripalmitin 0.30 - - 0.30 
[1,1,1-
13
C3] triolein 0.21 - - 0.21 
Total (g) 250.6 35.5 9.3 41.4 
% caloric intake  26 7 67 
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Table 3. Physico-chemical properties of fat used in the formulation of test breakfasts. 
1 
Mixture of milk fat + 
13
C-TAG tracers. 
2 
Diameter of the peak of maximum intensity measured by DLS. 
3 
Surface averaged diameter measured by LLS. 
4 
For Spread fat: calculated as the surface of an equivalent sphere of 40 g. For Emulsion: calculated 
from the specific surface area (m
2 
per g fat) calculated by the software, further multiplied by fat 
content in the meal. 
5 
Temperature at which the entire fat amount is in liquid form. 
 
Fat properties1 
Structure 
(type of breakfast) 
Droplet size2 
(µm) 
d32
3 
(µm) 
Fat surface 
area in meal4 
(m
2
) 
Melting 
temperature
5
 
(°C) 
Spread - - 0.006 42 
Emulsion 1.04 0.63 410 40 
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Table 4. Kinetic parameters after digestion of test breakfasts in NW vs obese subjects.  
Parameter Spread fat 40 g Emulsified fat 40 g  P value 
∆ CMRF TAG Normal-weight Obese Normal-
weight 
Obese Pmeal
1
 PBMI
1
 Pmealx 
BMI
1
 
Pmealx 
BMIxtime 
2
 
0-480 min: 
∆max (mmol/L) 
iAUC (mmol·min/L) 
tmax (min) 
Appearance-rate0-60 min 
(µmol/L/min) 
 
0.63 ± 0.13 
132.8 ± 29.1 
293 ± 23 
0.32 ± 0.27 
 
0.80 ± 0.12 
165.6 ± 23.1 
367 ± 33 
0.14 ± 0.32 
 
0.75 ± 0.09 
180.4 ± 28.2 
220 ± 42 
2.85 ± 0.72 
 
0.94 ± 0.25 
218.1 ± 53.2 
207 ± 25 
2.93 ± 0.6 
 
ns 
ns 
< 0.001 
<0.0001 
 
ns 
ns 
ns 
ns 
 
ns 
ns 
ns 
ns 
 
0-300 min: 
∆max (mmol/L) 
iAUC (mmol·min/L) 
tmax (min) 
 
0.56 ± 0.10 
81.4 ± 18.2 
233 ± 16 
 
0.53 ± 0.09 
57.6 ± 10.7 
267 ± 15 
 
0.74 ± 0.09 
127.7 ± 17.4 
167 ± 17 
 
0.94 ± 0.25 
159.3 ± 39.6 
193 ± 17 
 
0.05 
ns 
<0.0001 
 
ns 
< 0.01 
< 0.1 
 
ns 
ns 
ns 
 
300-480 min: 
∆max (mmol/L) 
iAUC (mmol·min/L) 
tmax (min) 
 
0.54 ± 0.13 
51.4 ± 12.9 
347 ± 5 
 
0.80 ± 0.12 
107.9 ± 17.7 
390 ± 23 
 
0.54 ± 0.11 
52.7 ± 11.2 
397 ± 19 
 
0.56 ± 0.14 
58.8 ± 14.7 
420 ± 24 
 
ns 
< 0.05 
< 0.05 
 
ns 
ns 
< 0.1 
 
ns 
ns 
ns 
 
< 0.05 
< 0.01 
< 0.1  
CMRF Size         
0-480 min: 
dmax (nm) 
tmax (min) 
Enlargement-rate0-60min 
(µmol/L/min) 
 
253 ± 34 
243 ± 25 
-0.06 ± 0.07 
 
494 ± 93 
307 ± 23 
-0.02 ± 0.11 
 
262 ± 20 
207 ± 30 
0.65 ± 0.11 
 
344 ± 58 
237 ± 33 
1.26 ± 0.78 
 
ns 
< 0.1 
< 0.05 
 
< 0.01 
0.1 
ns 
 
ns 
ns 
ns 
 
0-300 min: 
dmax (nm) 
tmax (min) 
 
246 ± 35 
180 ± 17 
 
296 ± 70 
200 ± 41 
 
239 ± 12 
200 ± 26 
 
336 ± 58 
193 ± 28 
 
ns 
ns 
 
< 0.1 
ns 
 
ns 
ns 
 
300-480 min: 
dmax (nm) 
tmax (min) 
 
195 ± 10 
337 ± 4 
 
451 ± 96 
367 ± 17 
 
207 ± 28 
340 ± 5 
 
236 ± 46 
360 ± 16 
 
< 0.1 
ns 
 
< 0.05 
< 0.05 
 
< 0.05 
ns 
 
0.055 
ns 
13
CO2 enrichment          
0-720 min: 
Cmax (%) 
AUC (%.min) 
tmax (min) 
Appearance-rate0-60 min 
(%/min) 
 
0.019 ± 0.001 
6.9 ± 0.5 
310 ± 21 
6.0 .10
-5
  
±1.7 .10
-5
 
 
0.013 ± 0.001 
4.8 ± 0.8 
347 ± 23 
2.0 .10
-5
  
± 0.5 .10
-5
 
 
0.019 ± 0.001 
7.7 ± 0.2 
267 ± 26 
13.6 .10
-5
  
± 1.9 .10
-5
 
 
0.016 ± 0.001 
6.4 ± 0.5 
267 ± 17 
9.8 .10
-5
  
± 0.8 .10
-5
 
 
< 0.01 
< 0.01 
< 0.01 
< 0.0001 
 
ns 
< 0.001 
ns 
< 0.01 
 
ns 
ns 
ns 
ns 
 
 
0-300 min: 
Cmax (mmol/L) 
AUC (%.min) 
tmax (min) 
 
0.018 ± 0.001 
2.9 ± 0.3 
283 ± 17 
 
0.011 ± 0.001 
1.6 ± 0.4 
293 ± 7 
 
0.019 ± 0.001 
3.9 ± 0.2 
257 ± 23 
 
0.016 ± 0.001 
3.2 ± 0.2 
260 ± 14 
 
< 0.05 
< 0.0001 
< 0.1 
 
< 0.0001 
< 0.0001 
ns 
 
< 0.05 
ns 
ns 
 
300-720 min: 
Cmax (mmol/L) 
AUC (%.min) 
tmax (min) 
 
0.019 ± 0.001 
3.9 ± 0.4 
333 ± 3 
 
0.013 ± 0.001 
3.2 ± 0.5 
360 ± 18 
 
0.017 ± 0.001 
3.8 ± 0.3 
330 ± 0 
 
0.016 ± 0.001 
3.1 ± 0.4 
330 ± 0 
 
ns 
ns 
< 0.1 
 
0.0001 
< 0.1 
ns 
 
< 0.05 
ns 
ns 
 
ns 
ns 
ns 
Data are means ± SEM, n=9 per group. Parameters calculated over the indicated time period: Cmax indicates maximum 
concentration; dmax indicates maximum diameter; ∆max indicates maximum concentration delta; iAUC, incremental area under the 
curve; AUC, area under the curve. P values (Pmeal, PBMI and PmealxBMI) obtained by ANOVA followed by post hoc Fisher PLSD. 
1
 P values of two-way ANOVA for meal and BMI effects and their interactions. 
2
 P values of two-way ANOVA for repeated measures regarding both time periods (before and after 300 min), for meal x BMI x 
time period interactions. 
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Figure Caption 
 
 
 
 
Figure 1. Postprandial profile after consuming spread fat (□, ) or emulsion (○, ): CMRF-
TAG (mM) in NW (A) and obese subjects (B) and corresponding iAUC; CMRF size (nm) in 
NW (C) and obese subjects (D); ApoB48 (mg/L) in NW (E) and obese subjects (F).  Data are 
means ±SEM, n=9 per group; Ptime, Pmeal and Ptimexmeal for postprandial period from 0 to 300 
min (repeated measures-ANOVA followed by post-hoc Fisher PLSD). 
(B) ** P< 0.01 for time 420 min emulsion vs spread fat (paired Student’s t-test); *P< 0.05 for 
emulsion vs spread fat at time 480 min and for iAUC0-300 (paired Student’s t-test); 
§
 P< 0.05 
for obese vs NW regarding spread fat iAUC300-480 (unpaired Student’s t-test). 
(D) *P< 0.05 for time 120 min emulsion vs spread fat (paired Student’s t-test) 
(C-D) 
§§
 P< 0.01 for time 120 min obese vs NW subjects (unpaired Student’s t-test);   
(E-F) * P< 0.05 for time 120 min emulsion vs spread fat (paired Student’s t-test), § P< 0.05 
for time 120 min obese vs NW subjects (unpaired Student’s t-test).    
 
 
 
Figure 2. Postprandial concentration profile and iAUC of total plasma lipids of 
13
C-palmitic 
acid (mM) and 
13
C-oleic acid (mM) in NW (A & C, respectively) and obese subjects (B & D, 
respectively) consuming spread fat (□, ) or emulsion (○, ). (E) Fecal excretion of 13C- 
palmitic acid and 
13
C-oleic acid in NW (white bars) and obese subjects (black bars) 
consuming spread fat (plain bars) or emulsion (droplet pattern bars). 
Data are means ±SEM, n=9 per group. 
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(A-B-C-D) Ptime, Pmeal and Ptimexmeal for postprandial period from 0 to 300 min (repeated 
measures-ANOVA followed by post-hoc Fisher PLSD).  
(A-B) *P< 0.05 for obese iAUC 0-300 min emulsion vs spread fat (paired Student’s t-test),  
§
 P< 0.05 for spread fat iAUC 0-300 min obese vs NW subjects (unpaired Student’s t-test), 
$
P< 0.1 for obese iAUC 0-480 min emulsion vs spread fat (paired Student’s t-test); (C-D)  
*P< 0.05 for obese iAUC 0-300 min emulsion vs spread fat (paired Student’s t-test), § P< 0.05 
for spread fat iAUC 0-300 min obese vs NW subjects (unpaired Student’s t-test); (E) no 
common letter with another bar indicates a statistical difference, P< 0.001 (ANOVA followed 
by post-hoc Bonferroni). 
 
 
 
Figure 3. Postprandial concentration profile of insulin (mUI/L) and NEFA (µM) in NW (A & 
C, respectively) and obese subjects (B & D, respectively) consuming spread fat (□, ) or 
emulsion (○, ). (E) 13C-enrichment of plasma NEFA at 120 min, estimating so-called 
apparent fatty acid ―spillover‖ in NW (white bars) and obese subjects (black bars) consuming 
spread fat (plain bars) or emulsion (droplet pattern bars).  
Data are means ±SEM, n=9 per group; Ptime, Pmeal and Ptimexmeal for postprandial period from 0 
to 300 min (repeated measures-ANOVA followed by post-hoc Fisher PLSD). 
(C) **P< 0.01 for NW subjects at 120 min emulsion vs spread fat (paired Student’s t-test); 
(D) *P< 0.05 for obese subjects at 120 min emulsion vs spread fat (paired Student’s t-test); 
(E) *P< 0.05 for NW subjects at 120 min emulsion vs spread fat (paired Student’s t-test);  
**P< 0.01 for obese subjects at 120 min emulsion vs spread fat (paired Student’s t-test); 
ANOVA analysis revealed meal effect (P<0.01) and BMI effect (P<0.01) but no significant 
meal x BMI interaction. 
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Figure 4. Postprandial profile of 
13
C-appearance in breath in NW subjects (A) and obese 
subjects (B) consuming spread fat (□, ) or emulsion (○, ); (C) Exogenous lipid fate, 
either oxidized (white), lost in feces (black) or stored (grey, calculated as ―total – 
(lost+oxidized)‖) in NW and obese subjects over 480 min; (D) Oxidation of intestinally 
absorbed lipids over 480 min in NW (white bars) and obese subjects (black bars) consuming 
spread fat (plain bars) or emulsion (droplet pattern bars); (E) Total lipid oxidation (total bar) 
and fraction of cumulative exogenous lipid oxidation (dashed part) over 480 min after 
consuming test breakfasts in NW vs obese subjects. 
Data are means ±SEM, n=9 per group. 
(C-D-E) * P< 0.05 for NW subjects and ** P< 0.01 for obese subjects emulsion vs spread fat 
(paired Student’s t-test). ANOVA analysis revealed no significant meal x BMI interaction 
(P=0.087). 
